Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Morphine vs Dexmedetomidine for Post-Mastectomy Pain
NCT02935933Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Oct 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of morphine and dexmedetomidine in acute pain and chronic pain (3 arms), sponsored by Assiut University. Primary endpoint: Total dose of morphine consumption at 48 hours. Status: unknown.
02
Drugs
morphinedexmedetomidine
03
Conditions
acute painchronic pain
Beyond the preview
Go deeper on NCT02935933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02935933.